Skip to main content
. 2022 Apr 12;41:139. doi: 10.1186/s13046-022-02333-1

Table 1.

Characteristics of patients and samples involved in the study

ID SAMPLE Gender Clinical Age Clinical IDH1 EGFRvIII TERT PROMOTER Clinical Pathology
Patient #1 M 79 WT NO C228T GBM
Patient #2 M 76 WT NO C228T GBM
Patient #8 M 76 WT YES C228T GBM
Patient #9 M 79 WT YES C228T GBM
Patient #14 F 80 WT NO C228T GBM
Patient #11 M 71 WT NO C228T GBM
Patient #6 F 52 WT NO C250T GBM
Patient #12 M 43 WT NO C228T GBM
Patient #7 F 44 WT NO C228T GBM -GLIOSARCOMA
Patient #13 M 42 WT NO C228T GBM
Patient #16 M 70 WT NO C228T GBM
Patient #17 F 72 WT NO C250T GBM
Patient #3 M 62 WT NO C228T GBM
Patient #5 F 56 WT NO C228T GBM
Patient #10 F 73 WT YES C228T GBM
Patient #15 M 62 WT NO C228T GBM